Cita APA (7a ed.)

XQ, T., XW, N., HL, X., L, Z., DL, Z., B, C., . . . YZ, Z. (2017). Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction. Dove Medical Press.

Cita Chicago Style (17a ed.)

XQ, Tian, Ni XW, Xu HL, Zheng L, ZhuGe DL, Chen B, Lu CT, Yuan JJ, y Zhao YZ. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.

Cita MLA (8a ed.)

XQ, Tian, et al. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.

Precaución: Estas citas no son 100% exactas.